(Q69782447)

English

Combined treatment of advanced malignant melanoma with coumarin and cimetidine. A phase II study

scientific article published on 01 January 1987

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

3829053

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3829053%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 October 2019

title

Combined treatment of advanced malignant melanoma with coumarin and cimetidine. A phase II study (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

3829053

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3829053%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 October 2019

author name string

L Pedersen

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed ID

3829053

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3829053%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 October 2019

C Rose

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

3829053

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3829053%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 October 2019

E Langvad

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed ID

3829053

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3829053%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 October 2019

publication date

1 January 1987

1 reference

stated in

Europe PubMed Central

PubMed ID

3829053

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3829053%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 October 2019

published in

Cancer Immunology, Immunotherapy

1 reference

stated in

Europe PubMed Central

PubMed ID

3829053

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3829053%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 October 2019

volume

24

1 reference

stated in

Europe PubMed Central

PubMed ID

3829053

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3829053%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 October 2019

issue

2

1 reference

stated in

Europe PubMed Central

PubMed ID

3829053

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3829053%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 October 2019

page(s)

178-179

1 reference

stated in

Europe PubMed Central

PubMed ID

3829053

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3829053%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 October 2019

exact match

https://scigraph.springernature.com/pub.10.1007/bf00205597

0 references

cites work

Endocrine treatment with anti-estrogen, anti-androgen or progestagen of advanced malignant melanoma: three consecutive phase II trials

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/3829053

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metastatic malignant melanoma: regression induced by combined treatment with interferon [HuIFN-alpha(Le)] and cimetidine

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/3829053

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

(Q69782447)

Combined treatment of advanced malignant melanoma with coumarin and cimetidine. A phase II study

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)